0001169245-20-000016.txt : 20200214
0001169245-20-000016.hdr.sgml : 20200214
20200214183859
ACCESSION NUMBER: 0001169245-20-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burkhardt Glen
CENTRAL INDEX KEY: 0001803271
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 20622538
MAIL ADDRESS:
STREET 1: C/O PHASEBIO PHARMACEUTICALS, INC.
STREET 2: 1 GREAT VALLEY PKWY.,SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4
1
wf-form4_158172352213967.xml
FORM 4
X0306
4
2020-02-12
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001803271
Burkhardt Glen
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
0
1
0
0
VP, Human Resources
Employee Stock Option (right to buy)
5.19
2020-02-12
4
A
0
55000
0
A
2030-02-12
Common Stock
55000.0
55000
D
Employee Stock Option (right to buy)
5.19
2020-02-12
4
A
0
20000
0
A
2030-02-12
Common Stock
20000.0
20000
D
The shares subject to the option shall vest in equal monthly installments over 48 months from February 12, 2020, subject to the reporting person's continued service through each such date.
One-fourth (1/4th) of the shares vest one year after the initial vesting date of March 15, 2019; the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the first anniversary of the initial vesting date, subject to the Reporting Person's continuous service as of each such date.
/s/ John Sharp, Attorney-in-fact
2020-02-14